Treatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin)
Dana S HardinOhio State University and Columbus Children’s Hospital, Columbus, Ohio, USAAbstract: Somatotropin (growth hormone, GH) of recombinant DNA origin has provided a readily available and safe drug that has greatly improved management of children and adolescents with GH deficien...
Guardado en:
Autor principal: | Dana S Hardin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1758e43d49e74764a952c0fea69fc65b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
por: J Paul Frindik, et al.
Publicado: (2010) -
Isolated Growth Hormone Deficiency and Idiopathic Short Stature: Comparative Efficiency after Growth Hormone Treatment up to Adult Height
por: Ana-Belen Ariza-Jimenez, et al.
Publicado: (2021) -
Association between triglyceride glucose index and peak growth hormone in children with short stature
por: Qianqian Zhao, et al.
Publicado: (2021) -
Effect of Weekly Long-Acting Growth Hormone Replacement Therapy Compared to Daily Growth Hormone on Children With Short Stature: A Meta-Analysis
por: Liyan Ma, et al.
Publicado: (2021) -
Molecular genetic analysis and growth hormone response in patients with syndromic short stature
por: Huihui Sun, et al.
Publicado: (2021)